论文部分内容阅读
目的:通过客观评价慢性乙肝患者对核甘类药物治疗的依从性,总结提升慢性乙肝患者用药依从性的治疗方法。方法:以随机方式选择河南省长葛县人民医院2013年06月至2015年06月收取的100例慢性乙肝患者,以问卷调查方式对患者病情状况、性别、药物种类、年纪、经济条件以及文化程度等信息,并予以核苷类药物治疗,观察不同的影响条件下慢性乙肝患者对核苷类药物治疗的依从性。结果:入选患者中,59例(59.00%)慢性乙肝患者对核苷类药物治疗的依从性偏好,41例(41.00%)慢性乙肝患者对核苷类药物治疗的依从性偏差。结论:一般而言,慢性乙肝患者对核苷类药物治疗的依从性通常会受多种因素影响,因此在临床诊治中,临床医师需以患者病情状况、临床信息为出发点,予以个性化治疗,从而提升患者治疗的依从性。
OBJECTIVE: To objectively evaluate the compliance of patients with chronic hepatitis B to treatment with kanamycin, and to summarize the treatment methods to improve the compliance of patients with chronic hepatitis B. Methods: A total of 100 chronic hepatitis B patients were collected from Changge People ’s Hospital of Henan Province from June 2013 to June 2015 by questionnaire. The patients’ condition, sex, type of medicine, age, economic condition and culture Degree and other information, and be treated with nucleoside drugs to observe the different effects of chronic hepatitis B patients with compliance to the treatment of nucleoside drugs. Results: Among the selected patients, 59 (59.00%) patients with chronic hepatitis B had a preference for nucleoside drug treatment and 41 (41.00%) patients with chronic hepatitis B had a deviation from the compliance with the nucleoside drug treatment. Conclusion: In general, the compliance of nucleoside drugs in chronic hepatitis B patients will usually be affected by many factors. Therefore, clinicians should make personalized treatment based on the patient’s condition and clinical information in clinical diagnosis and treatment, Thereby enhancing patient compliance with treatment.